High Tower Advisors, LLC Alpha Tau Medical Ltd. Transaction History
High Tower Advisors, LLC
- $71.3 Billion
- Q1 2025
A detailed history of High Tower Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, High Tower Advisors, LLC holds 230,704 shares of DRTS stock, worth $687,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
230,704
Previous 230,704
-0.0%
Holding current value
$687,497
Previous $715,000
19.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.59MCall Options Held
0Put Options Held
0-
Hoyle Cohen, LLC269KShares$801,8820.05% of portfolio
-
Kovitz Investment Group Partners, LLC226KShares$674,4330.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY223KShares$663,0910.06% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$197,6510.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il59.8KShares$178,3470.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $206M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...